GILD - Gilead Sciences, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual
Subscribe to Premium to download historical data

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
22,449,000
22,449,000
22,127,000
26,107,000
30,390,000
Cost of revenue
4,675,000
4,675,000
4,853,000
4,371,000
4,261,000
Gross profit
17,774,000
17,774,000
17,274,000
21,736,000
26,129,000
Operating expenses
Research development
9,106,000
9,106,000
5,018,000
3,734,000
5,098,000
Selling general and administrative
4,381,000
4,381,000
4,056,000
3,878,000
3,398,000
Total operating expenses
13,487,000
13,487,000
9,074,000
7,612,000
8,496,000
Operating income or loss
4,287,000
4,287,000
8,200,000
14,124,000
17,633,000
Interest expense
995,000
995,000
1,077,000
1,118,000
964,000
Total other income/expenses net
1,868,000
1,868,000
676,000
523,000
428,000
Income before tax
5,160,000
5,160,000
7,799,000
13,529,000
17,097,000
Income tax expense
-204,000
-204,000
2,339,000
8,885,000
3,609,000
Income from continuing operations
5,364,000
5,364,000
5,460,000
4,644,000
13,488,000
Net income
5,386,000
5,386,000
5,455,000
4,628,000
13,501,000
Net income available to common shareholders
5,386,000
5,386,000
5,455,000
4,628,000
13,501,000
Basic EPS
-
-
4.20
3.54
10.08
Diluted EPS
-
-
4.17
3.51
9.94
Basic average shares
-
-
1,298,000
1,307,000
1,339,000
Diluted average shares
-
-
1,308,000
1,319,000
1,358,000
EBITDA
-
7,559,000
10,305,000
15,933,000
19,219,000
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more